Nutritional Content of Breast Milk From Mothers of Premies
NCT ID: NCT01050192
Last Updated: 2017-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2009-12-31
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Human Milk Cream as a Caloric Supplement in Pre-Term Infants
NCT01487928
Using Mother's Raw Milk Could Improve Breastfeeding in Hospitalized Neonates
NCT02819193
LACTACOL 01 - Impact of Breast Milk on the Neurodevelopment of Preterm Newborns
NCT01493063
Early Use of Raw Milk and Breastfeeding Continuation
NCT03938675
Pre/Term Milk Profiling
NCT02052245
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Reasonable likelihood of survival of infant to 28 days
* Infant on/ready for oral feeding by DOL 7 days
* Willing to provide breast milk for their baby
* Able to produce at least 7mL breast milk per feeding
* Willing to abide by requirements of the study protocol
* Documentation of informed consent
Exclusion Criteria
* Medically unsuitable to provide breast milk to her baby
* Maternal age \<18 years of age
23 Weeks
30 Weeks
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prolacta Bioscience
INDUSTRY
Pediatrix
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amy Kelleher
Director Clinical Trial Operations
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Reese Clark, MD
Role: PRINCIPAL_INVESTIGATOR
Greenville Memorial Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Greenville Memorial Hospital
Greenville, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro0001271
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.